Head And Neck Cancer Partnering 2007-2012

By Author: Bharat Book
Total Articles: 682
Comment this article

The Head and Neck Cancer Partnering 2007-2012 report provides understanding and
access to the head and neck cancer partnering deals and agreements entered into
by the worlds leading healthcare companies.

* Trends in head and neck cancer partnering deals

* Top head and neck cancer deals by value

* Deals listed by company A-Z, industry sector, stage of development, technology
type


http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/head-and-neck-cancer-partnering-2007-2012.html



Description

The Head and Neck Cancer Partnering 2007-2012 provides understanding and
access to the head and neck cancer partnering deals and agreements entered into
by the worlds leading healthcare companies.
Business Research



The report provides an analysis of head and neck cancer ...
... partnering deals. The
majority of deals are discovery or development stage whereby the licensee
obtains a right or an option right to license the licensors head and neck cancer
technology. These deals tend to be multicomponent, starting with collaborative
R&D, and commercialization of outcomes.



Understanding the flexibility of a prospective partner’s negotiated deals terms
provides critical insight into the negotiation process in terms of what you can
expect to achieve during the negotiation of terms. Whilst many smaller companies
will be seeking details of the payments clauses, the devil is in the detail in
terms of how payments are triggered – contract documents provide this insight
where press releases do not.



This data driven report contains over 30 links to online copies of actual head
and neck cancer deals and contract documents as submitted to the Securities
Exchange Commission by companies and their partners, where available. Contract
documents provide the answers to numerous questions about a prospective
partner’s flexibility on a wide range of important issues, many of which will
have a significant impact on each party’s ability to derive value from the deal.



The initial chapters of this report provide an orientation of head and neck
cancer partnering trends.



Chapter 1 provides an introduction to the report, whilst chapter 2 provides an
overview of the trends in head and neck cancer partnering since 2007, including
a summary of deals by industry sector, stage of development, deal type, and
technology type. Numerous tables provide outline financial trends.



Chapter 3 provides an overview of the leading head and neck cancer deals since
2007. Deals are listed by headline value, signed by bigpharma, most active
bigpharma. Where the deal has an agreement contract published at the SEC a link
provides online access to the contract.



Chapter 4 provides a comprehensive directory of head and neck cancer partnering
deals signed and announced since 2007. The chapter is organized by company A-Z,
stage of development at signing, deal type (collaborative R&D, co-promotion,
licensing etc), and technology type. Each deal title links via Weblink to an
online version of the deal record, and where available the contract document,
providing easy access to each contract document on demand.



In conclusion, this report provides everything a prospective dealmaker needs to
know about partnering in the research, development and commercialization of head
and neck cancer technologies and products.



Report scope

Head and Neck Cancer Partnering 2007-2012 is intended to provide the reader
with an in-depth understanding and access to head and neck cancer trends and
structure of deals entered into by leading companies worldwide.




For more information kindly visit :



Head and Neck Cancer Partnering 2007-2012



Or



Bharat Book Bureau

Tel: +91 22 27810772 / 27810773

Fax: + 91 22 27812290

Email: info@bharatbook.com

Website: www.bharatbook.com

Follow us on twitter:
http://twitter.com/#!/Sandhya3B